Condition
DMMR Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 DMMR Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (1), Australia (1), United States (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Oral MOMA-341 for advanced or metastatic MSI-H or dMMR solid tumors
This trial will test whether the oral drug MOMA-341, alone or with irinotecan or immunotherapy, can be safe and show anti-tumor activity in adults with advanced or metastatic MSI-H/dMMR solid tumors who have progressed after prior PD-(L)1 therapy.
-
Using immune checkpoint inhibitors to preserve organs in non-metastatic gastric or colon cancers
This study is testing a new combination of immune treatments to see if it can help people with non-metastatic gastric or colon cancers keep their organs and improve their health before surgery.
Related topics
Quick answers
How many DMMR Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (1 trial), Australia (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.